New targeted drug enters human testing for Tough-to-Treat cancers
Disease control
Recruiting now
This is the first study in people testing an experimental drug called CUSP06. It aims to see if the drug is safe and can help control advanced ovarian cancer and other solid tumors that have stopped responding to standard platinum-based chemotherapy. The study will enroll about 2…
Phase: PHASE1 • Sponsor: OnCusp Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC